title: [What is the opinion of Spanish internists on osteoporosis?].
abstract: OBJECTIVE
  To conduct an opinion survey on osteoporosis in Spanish internists.
  
  
  METHODS
  Survey sent by mail and by personal visit to members of the Spanish Internists Society. Collection of data on opinion on the disease, diagnostic and therapeutic attitude and means available (general laboratory analyses, conventional radiology, biochemical markers of bone remodeling, densitometry and ultrasounds) and preference when choosing a certain treatment.
  
  
  RESULTS
  A total of 538 internists answered. More than 90% of those surveyed consider that osteoporosis is a disease that should be treated by internists. A total of 93% consider that osteoporosis is a prevalent disease. More than 80% have access to densitometry.
  
  
  CONCLUSIONS
  The majority of Spanish internists consider that osteoporosis is a disease that should be treated by internists and that it is a disease that enters into their action scope. In general, they have the means necessary for its study and treatment. Bisphosphonates constitute the drug of choice and calcium and vitamin D supplements are indicated in almost all the cases.
authors.affiliation: Universidad de Las Palmas de Gran Canaria, C/Espronceda 2, 35005 Las Palmas de Gran Canaria. manuelsosah@canariastelecom.com
authors.forename: M
authors.initials: M
authors.lastname: Sosa Henríquez
authors.forename: J
authors.initials: J
authors.lastname: Filgueira Rubio
authors.forename: J A
authors.initials: JA
authors.lastname: López-Harce Cid
authors.forename: M
authors.initials: M
authors.lastname: Díaz Curiel
authors.forename: C
authors.initials: C
authors.lastname: Lozano Tonkin
authors.forename: A
authors.initials: A
authors.lastname: del Castillo Rueda
authors.forename: P
authors.initials: P
authors.lastname: Sánchez Molini
authors.forename: J
authors.initials: J
authors.lastname: Montes Santiago
authors.forename: C
authors.initials: C
authors.lastname: Serrano Fernández
authors.forename: B
authors.initials: B
authors.lastname: Díaz López
authors.forename: R
authors.initials: R
authors.lastname: Pérez Cano
authors.forename: J A
authors.initials: JA
authors.lastname: Blázquez
authors.forename: N
authors.initials: N
authors.lastname: Ortego Centeno
authors.forename: R
authors.initials: R
authors.lastname: Tirado Miranda
authors.forename: J R
authors.initials: JR
authors.lastname: Sánchez Linares
authors.forename: X
authors.initials: X
authors.lastname: Nogués Solán
authors.forename: J
authors.initials: J
authors.lastname: Farrerons Minguela
authors.forename: F
authors.initials: F
authors.lastname: Escobar Jiménez
authors.forename: J
authors.initials: J
authors.lastname: del Pino del Montes
authors.forename: J
authors.initials: J
authors.lastname: González-Macías
authors.forename: C
authors.initials: C
authors.lastname: Gómez Alonso
mesh_terms: D000368:Aged; D001291:Attitude of Health Personnel; D003720:Densitometry; D004164:Diphosphonates / Q000627:therapeutic use; D006801:Humans; D007388:Internal Medicine; D008875:Middle Aged; D010024:Osteoporosis / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology*; D013030:Spain; D011795:Surveys and Questionnaires
chemical_list: D004164:Diphosphonates